HOSPITAL - HOME CARE - EMERGENCY

13
HOSPITAL - HOME CARE - EMERGENCY INNOVATIVE MEDICAL DEVICES FOR INFECTION CONTROL AND THE COMFORT AND CARE of dependent, bedridden or incontinent people AS WELL AS FOR EMERGENCY SITUATIONS www.drhelewa.care Enterococcus Clostrtidium

Transcript of HOSPITAL - HOME CARE - EMERGENCY

HOSPITAL - HOME CARE - EMERGENCY

InnovatIve medIcal devIces for InfectIon control and the comfort and care

of dependent, bedridden or incontinent people

as well as for emergency sItuatIons

www.drhelewa.care

Enterococcus

Clostrtidium

Best Sellers!

www.drhelewa.care2

www.drhelewa.care3

O U R M I S S I O N

l Hygiene and infection control

l Good working conditions and safety for health workers and caregivers

l Patient dignity and comfort

l Premium innovative quality products that are cost effective

Dr. Laurent Helewa and Dr. Mayer Helewa,Inventors of the 1st bedpan liner

O U R S T O R Y

20 years of innovation...Dr. Helewa created the 1st bedpan liner and

super-absorbent hygienic bags in 1998 and has continued to innovate for medical hygiene ever since

... Recognized a number of times with...Awards and Distinctions

Paris, France 1998, Geneva, Switzerland 2011,Voted Best new product

Caregiver.com 2012 & 2014, Orlando USAMedical Design, Excellence Award NY USA 2015

...Endorsed throughout the world!More than 200 million uses around the world:

in hospitals, nursing homes and for home healthcare, during medical transport and in emergency situations.

T O D AY:

2 new patents,new technologies

and materials

A new v2.0 generation of more efficient, more cost-effective

super-absorbent hygienic bags

Quality and serviceManufacturer: Medistock s.a.s,

(www.medistock.fr), EN 13485 certified(quality management systems

for the medical device industry)

C O N T E N T S

Best sellers 2About us 3

Management of excreta of incontinent patients 4-5Risks: infectious, physiologic, occupational

Official recommendations - Budgetary aspects

In hospitals 6

In home healthcare, in nursing Homes 7

Selection criteria for super-absorbent hygienic bags 8

Patented innovations 9Hypoallergenic, Alveol-Technology,

600 ml Pad, Hands 100% protected

Options: Antimicrobial / Oxo-biodegradable 10

Comparison / competition 11The super-absorbent hygienic bagsBedpan liner 12

Bedpan kit 13

Commode liner 14

Toilet liner 15

Vomit bag 16

Male urinal 17

Bathing bedridden patients 18-19Risks: infectious, physiologic, occupational

Official recommendations - Budgetary aspects

Selection criteria for pre-moistened wash glove 20

Technical features 21

No-rinse wash-glovesWash-gloves for bathing 22

Wash-gloves for shampooing 23

Flyer 24600 ml

20 oz

I N N O VAT I O N

New! 2 international patents…

Patented integrated holder: caregiver’s hands 100% protected

Patented « Alveol Technology » super-absorbent pad: does NOT release powder, absorbs more and faster

The only hypoallergenic & dermatologically tested absorbent hygienic bags of the market

THE

www.drhelewa.care4

www.drhelewa.care5

Management of excreta

Excreta: - Vomit, Urine, Feces- A reservoir of micro-organisms that can potentially lead to infections with a high capacity for spreading:l Feces: 107 to 109 bacteria/g of feces

l Urine: 108 to 109 ESBL - producing E. coli/day in urinary infections

l Vomit: 107 norovirus for 20-30 ml of vomit (gastroenteritis)

1

Bacterial risk related to feces:- The digestive tract is a reservoir for many bacteria families such as: Escherichia coli, Klebsiella pneumoniae, vancomycin-resistant enterococci, Clostridium difficile, etc.

Enterobacteria: - Responsible for 38 to 50% of Healthcare Associated Infections (HAI) and Nosocomial Infections (NI)

- Resistant to antibiotics

- Emergence of “Highly Resistant Bacteria” and “Super bacteria”

- Stability in the environment up until: l Enterococcus faecalis: 5 days, l Rotavirus: 10 days, l Norovirus: 1 week, l Escherichia coli: 1 week, l Spores of Clostridium difficile, VRE, MRSA, Acinetobacter: 4 to 5 months1

Impact of NosocomialInfections2: - Developed countries: 5 to 10 % of patients (up to 30% / intensive care unit)

- Developing countries: 2 to 3 times more

- 7th cause of death in the world: 2 million deaths per yearExamples (no. NI, no. deaths/year) - USA: 2 million NI, 80,000 deaths- France: 750,000 NI, 4200 to 9000 deaths- Mexico: 450,000 NI, 41,000 deaths

Major Challenge

Management of excreta and hygiene in dependent patients: Adopt best practices, use the bestmethods and right equipment to:- Prevent risk of infection: Cross transmission (Interhuman, equipment, patient environment)

- Improve working conditions and the safety of health workers and caregivers

- Promote patient mobility (prevention of undue incontinence), modesty and dignity

- Reduce direct (equipment, consumables, work time) and indirect costs (consequence of NI)

Continent - dependent patientsHigh-risk handling, poor hygieneBedpans, commodes, urinals, etc. are reservoirsof pathogenic micro-organisms.Handling them exposes the caregiver, patient and environment to microbial contamination.

Traditional hygienic methods: - Manual cleaning, ungrateful task, tedious, the most expensive and risky: to be outlawed.- Bedpan washer or macerator: heavy equipment and expensive, with frequent malfunctions (2/3 bedpan washers: malfunction more than once a year3), do not resolve the problem of carrying full bedpans to the washing equipment (risk of transmission throughout the facility).Example: Survey of AP-HP hospitals in 20123

High-risk handling of bedpans: 79% of the wards.

Continent - dependent patients - Traditional bed bath4: Potentially contaminatingBedpan = reservoir of pathogensRisk of being interrupted during the bath.

DISCOVER THE v 2.0 OF OUR SOLUTIONSSince 1998, 200 million version 1 products were sold, easy to use, the safest on the market5,

recommended by hygienists3, innovative (2 new patents) and, above all, … the most cost-efficient!

D.Trystram - V.jarlier - 18 septembre 2012 - BMR-AP-HP Collégiale de BVH

Clostridium difficile in the USA

Enterococcus

Clostrtidium

Resistant E. Coli around the world

Incidence of ESBLin E. coli, pneumoniae, E. cloacae

Example of a “clean” bedpan put away in a resuscitation room3

Collection equipment: bedpans, commodes, urinals: the weak chains in excreta management

Sources (extracts and adaptations): 1- The Role Played by Contaminated Surfaces in the Transmission of Nosocomial Pathogens • Author(s): Jonathan A. Otter, Saber Yezli, Gary L. French Source: Infection Control and Hospital Epidemiology, Vol. 32, No. 7 (July 2011), pp. 687-699 Published by: The University of Chicago Press on behalf of The Society for Healthcare Epidemiology of America 2-WHO, Health care-associated infections FACT SHEET 3- Bulletin du CClin Paris-Nord n°41, décembre 2012, Enquête sur la gestion des excreta dans les hôpitaux de l’AP-HP, Margaux Lepainteur, Simone Nérome, Gisèle Bendjelloul, Brigitte Cottard-Boulle, Catherine Monteil, Michèle Huang, Vincent Jarlier, Sandra Fournier et le réseau des équipes d’hygiène de l’AP-HP 4-Photo toilette au lit 2010 Resclin-Champagne-Ardenne 5- Analyse comparative des équipements de traitement des bassins Agence d’Evaluation des Technologies et des Modes d’Intervention en Santé (AETMIS 2009): Vol 5: N4

www.drhelewa.care6

www.drhelewa.care7

Super-absorbent hygienic bags: ensure safe collection, transport and elimination of excreta

Used by thousands of hospitals worldwideRecommended by hospital hygiene authorities

In home healthcare, as in nursing homes, respecting the fundamental needs6

of dependent residents is the caretakers’ mission (Assistant nurse, home caregiver, family).

Mobility is essential6

The partial or full loss of mobility poses significant problems at home in everyday acts,Including elimination and can lead to risks related to decubitus.7

Encouraging mobility is recommended to prevent functional incontinence due to restricted mobility: Prefer plastic collection devices (bedpan, commode chair with pail, urinal) to avoid very early diaper use, encouraging independence ;thus respecting the dignity of the dependent person.8

Due to consequences, sometimesunderestimated, excreta managementdemands increased vigilance fromhealth professionals.9

A study has shown that 23 to 65% of health professionals have been exposed to accidental splashes.10

Reduction in potential costs: The use of Personal Protection Equipment (PPE) fell, leading to savings of $3.15 to $4.15 for each bedpan use.4

In healthcare facIlItIes: recommended use In home healthcare: recommended use

Average infection rate:Proven decrease

Caregiving:Proven efficiency

Cost control: Proven savings

De novo incontinence:Mobility encouraged

Caregivers’ work:Conditions optimized

Patient well-being:Basic needs respected

ULTRA-RAPID ABSORPTION

600 ml 20 oz

Cost comparator for handling excreta collection devices5

Annual cost in euros agent time included

Bedpan washer 1

€4,100.90

Bedpan washer 2

€4,229.32

Macerator

€3,280.72

Absorbent bag

€3,084.96

Manual cleaning

€3,280.72

Rate of infections associated with VRE - 2009 - 2010 - 2011

Rate of VRE-related nosocomial infections Average rate of nosocomial infections

Results4: Decrease

- in VRE-related infections (from 1.53 to 0.26)

- in patient environmental contamination

- in number of steps in nursing care (from 15 or 20 to 9)

Sources (extracts and adaptations): 1- From APIC Implementation Guide. Guide to Preventing Clostridium Difficile infections. February 2013, 2- Analyse comparative des équipements de traitement des bassines de lit (VOL. 5 : No 4) - 2009 - Québec, Canada - AETMIS (Agence d’Evaluation des Technologies et des Modes d’Intervention en Santé), 3- Gestion des excrétas Recommandations officielles du 27/09/2012 France - CLIN Central de l’APHP (Assistance publique Hôpitaux de Paris) 4 : Vitale, E. (2011, May). Safer Panhandling to Reduce the Rate of Vancomycin Resistant Enterococci - Giving staff the right tools to safely and efficiently do their job. Poster session presented at the CHICA-Canada National Education Conference, Toronto, ON 5- Outil est mis gracieusement à disposition des établissements de santé par l’ARLIN Haute Norman-die. Les établissements sont tenus de valider et vérifier leurs données. Pour tout renseignements complémentaires contacter [email protected] , date de réalisation 10/04/2014 -6- Henderson, V., La nature des soins infirmiers (traduction de l’édition américaine The Principles and Practice of Nursing de 1994), Inter Editions, Paris, France, 1994 -7 «Complications du décubitus, Pr Bernard Fouquet, Johann Beaudreuil, EMC Kinésithérapie, Elsevier 2000» 8: Prévenir la dépendance iatrogène liée à l’hospitalisation chez les personnes âgées - HAS : Haute Autorité de santé, France 2 CNPG : Collège na-tional professionnel de gériatrie, France – 9: ACTUALISATION DES PRÉCAUTIONS STANDARD - HYGIÈNES - VOLUME XXV - N° HORS SÉRIE - JUIN 20174 10– Davanzo E, Frasson C, Morandin M, Trevisan A. Occupational blood and body fluid exposure of university health care workers. Am J Infect Control 2008; 10: 753-756

« Line the commode with a plastic bag and absorbent material to reduce healthcare exposure to fecal material.1 »

« Use disposable excreta collection bags containing an absorbent for all bedpan using patients.3 »

« Hygienic Bags is a recent single use concept that allows for the safe disposal of human waste. Moreover, the hygienic bag method requires no equipment or infrastructure.2 »

APIC AETMIS CCLIN APHP

www.drhelewa.care8

www.drhelewa.care9

The new super-absorbent hygienic bags:

Protection through containment

Bedpan liner - Commode liner - Toilet liner - Male urinal - Vomit bag

5 models to optimizeexcreta management

- The bag hermetically seals excreta, the pad gels the excreta for maximum safety

- Odors are contained both mechanically (closing the bag) and chemically (The pad’s polymers mitigate the effects of the transformation of urea into ammonia).

- Better hygiene, a single-use product, time saved and simple, risk-free elimination

No more accidental splashes, thankless tasksand persistent odors

l

Infection control,fight against nosocomial infections

l

Improved working conditions and safetyfor health workers and caregivers

l

Patient environment, modesty, dignityand comfort respected.

100% efficient absorbent hygienic bags Easy to use, Cost-effective

Medical grade Hygiene &

Infection control Product

Selection criteria for super-absorbent hygienic bags

Hypoallergenic

Wrapped pads

Absorption 600 ml

In hospItalsLES

600 ml 20 oz

600 ml 20 oz

THE

General features of the ideal product for preventing and caring for Incontinence Associated Dermatitis (IAD): ... hypoallergenic.1

The patient is in prolonged contact with the bag (bedpan liner, toilet or commode liners, male urinal); caregivers have repeated contact.It is recommended that hypoallergenic bags be used that have been dermatologically tested, to avoid problems of skin irritation and skin or respiratory allergy, in particular for fragile patients or those with sensitive skin2.

- The adult bladder can hold a maximum capacity of 300 to 600 ml. Any amount above that is pathological and the bladder may become enlarged (the bladder can hold up to a liter of urine before rupturing).4

- Intestinal infections, secretory or ulcerative colitis: volume of liquid stool > 500 ml/day.5

- A study has shown that in a 3-month period, 37% of nurses reported an accidental exposure to splashing.6 - Recommended technique: Wait for the liquid to gel.7

Regular absorbent pads contain allergens: fragments of absorbent cellulose (fluff) and Super-AbsorbentPolymers (acrylates). To prevent these allergens from being discharged when dry and dispersed in the hygienic bag, or on the patient’s skin or in their surroundings, it is recommended to use absorbent pads, fully wrapped in a bodily fluid permeable envelope.

Regular absorbent pads:unwrapped and allergenic

Bladder: 300 to 600 ml

x25

Absorption of 600 ml of bodily fluids is recommended in order to handle most situations and minimize the risks of soiling, splashing or high-risk handling.

I N N O VAT I O N S

The only super-absorbent hypoallergenichygienic bags on the market that have been dermatologically tested. Tests HRIPT – TCFS (FDA registration) On request

Built-in supportUsers’ hands 100% protectedPatent pendingfor URI and VOM models.

New Super-Absorbent pad with Alveol-Technology® Wrapped: does not discharge cellulose particles or powder in the bag or on the skinPatent pending.

• Honeycomb texture: quicker and more absorbent • Ultra-fast absorption (< 3 min) of 600 ml / 800 ml / 1000 ml of bodily fluids (saline 0.9% ) EDANA protocol upon request

- Hypoallergenic, dermatologically tested - Reinforced, ergonomic box

- Wrapped, super-absorbent pad: *interior: microcellulose and super-absorbent polymers

*Envelope: permeable hypoallergenic paper - Recycled materials

Bag: PEMD, thinner, more resistant polyethylene (reduced plastic), satiny feel (does not stick to the skin)

- Options: Antimicrobial AM26 PEMD & Oxo-biodegradable OB5 PEMD*

*Verify availability depending on country

Technical data and composition

600 ml 20 oz

New! 2 international patents...THE

Sources (extracts and adaptations): 1: Beeckman D et al. Proceedings of the Global IAD Expert Panel. Incontinence associated dermatitis: moving prevention forward. Wounds International 2015. 2: Contact Allergy to Acrylates, An-thony Goon National Skin Centre, Singapore. Forum for Nord Derm Ven 2011, Vol. 16, No. 126 –– 3: Clinics in Dermatology, Volume 26, Issue 1, January–February 2008, Pages 45-51 , Skin interaction with absorbent hygiene products ,Author links open overlay panel BoRunemanPhD 4: Anesthesiology. 2009 May;110(5):1139-57. doi: 10.1097/ALN.0b013e31819f7aea. ; Postoperative urinary retention: anesthetic and perioperative considerations ; Baldini G1, Bagry H, Aprikian A, Carli F. – 5: LES FONDAMENTAUX DE LA PATHOLOGIE DIGESTIVE © CDU-HGE/Editions Elesevier-Masson - Octobre 2014 – 6: Doebbeling B, Vaughn TE, Mccoy KD, Beekmann SE, Woolson RF, Ferguson KJ. Percutaneous injury, blood exposure, and adherence to standard precautions: Are hospital-based health care providers still at risk? Clin Infect Dis 2003; 8: 1006-1013. – 7: La gestion des excreta au quotidien, 14ème journée du Réseau Régional d’Hygiène - ARLIN de Basse-Normandie 25/09/2014 Francine Delaisements – Murielle Siharath CH L’Aigle CH Flers.

« Acrylates have been used in super-absorbent polymers (e.g. in nappies). Acrylate skin allergy is frequently seen in the occupational as well as non-occupational setting. Skin allergies to acrylates are confirmed by patch testing 2 ».

« Skin problems due to the use of absorbent hygiene products... Improved product design features are believed to explain the decline in observed diaper dermatitis among infants. Where adult incontinence–related skin problems are concerned… Individuals with frail, sensitive skin or with skin diseases my preferably have to use high-quality products, equipped with superabsorbent polymers and water vapor–permeable back sheets, to minimize the risk of skin complications3 ».

www.drhelewa.care11

www.drhelewa.care10

2 optIons for even more effIcIent super-absorbent hygIenIc bags

comparIson of super-absorbent hygIenIc bags v1 / v2.0

• Efficacious antibacterial and antifungal action Active against 50 of Clostridium difficile strains and spores

• Long shelf life: 5 years before use Rapid degradation after use and elimination

1 month 18 months 24 months Bioassimilation

Waste management (excluding incineration, aerobic)

- Standard degradation of polyethylene: > 50 years- Degradation of OB+ polyethylene: rapid

OB+ oxo-biodegradable bags Additive incorporated directly in the bag’s material

- Long shelf life (use by date of 5 years)- Quick degradation following aerobic elimination

Reduce the impact of waste generated on the environment

Test performed according to standard JIS Z 2801:2010

A test on Escherichia coli and Staphylococcus aureus Significantly reduced (≈ 4 Log) the number of bacteria.

A test on Clostridium difficile spores significantly reduced their number by more than 5 Log (99.999%).

Test performed according to a method adapted from ISO 22196:2011

CareBag® bagwith AM26 additives

Efficacy on spores%

of r

educ

tion

in sp

ores

Control samplewithout additive AM51

With additive AM51

Spores of C. difficile

99.99999.98 99.99

0 0

Antibacterial efficacy

Control sampleWithout additive AM51*

With additive AM51

E. coli S.aureus

% o

f red

uctio

n in

bac

teria

Management of excreta > Risk of contamination:

- Patient environment contaminated- Task interrupted (bag not immediately thrown out)

A protective antimicrobial barrier> Tests conducted by independent laboratories

AM51 Anti-Microbial Bags > Additive incorporated directly in the bag’s material:

- Action against bacteria and fungus as well as spores- Active against 50 strains and spores of Clostridium difficile

OB+

AM51

Additive AM51 : • Registered with the European Union BPR, US-EPA • Compliant with 94/62/EC Directive on packaging and waste (no heavy metals) • Non-toxic, FDA and EPA approved.• Active on Clostridium difficile spores and 50 strains, especially following pathogenics strains: Aspergillus amstelodami, Aspergillus nidulans, Aspergillus niger, Candida albicans, Corynebacterium minutissimum, Corynebacterium spp, Enterobacter gergoviae, Escherichia coli, Escherichia coli 0157 H7, Klebsiella pneumoniae, Listeria monocytogenes, Mesophilic aerobes, Mucor racemosus, Myceliophthora thermophila, Penicillium chrysogenum, Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa, Pseudomonas cepacia, Pseudomonas putida, Saccharomyces cerevisiae, Salmonella enteritidis, Staphylococcus aureus, Staphylococcus aureus résistant à la méticilline (SARM), Trychophyton mentagrophytes.

* Additive OB+ : OB+ long-term storage liners (with a use-by date of 5 years) are biodegradable under aerobic conditions, heat, and/or sunlight The exact rate and extent of that degradation is unpredictable and depends on the amount of light and heat the product receives. OB5 plastic will not degrade and will not emit greenhouse gases under anaerobic conditions in landfills.

Warning: users are required to check if OB + is allowed in their country.

Aerobicdegradation

A M 5 1

O B +

New Super-Absorbent padwith Alveol-Technology®:

Honeycomb texture:Absorbs more and faster

Paper-wrapped:No longer disperses microcelluloseor powder in the bag or on the skin

2 patents pending:

Integrated holder l

Alveol-Technology Pad

Ergonomic reinforced

box

600 ml 20 oz

Alveol-Technology®

Integrated holder:The handsof the user

or the caregiverare protected

No more comingin contact withthe soiled area

No

+

+

Yes

Yes

Poor

No

No

No

No

Good

Yes

+ +

+ +

No

No

High

Yes

2

Yes

Yes

Cost-effective

BAG

Integrated holder “100% hand protection”

PAD

Bodily fluid absorption

Capacity

Speed

Disperses microcellulose and powder in the bag

Disperses microcellulose and powder on the skin

BOX

Quality

Suspension hole

PRODUCT

Patents

HypoallergenicDermatologically tested

Unique

PRICE

v 1Dr. Helewa

v 2.0

www.drhelewa.care13

www.drhelewa.care12

bedpan lIner 600

Ref: B60020 - Bag 60 x 40cm1 Box = 1 roll of 20 bags

1 2 3 4

600 ml 20 oz

New and Unique! “1 procedure” Hygiene Kits

1 pack contains:- 1 600 ml bedpan liner- 1 underpad(Absorbent 60x90 draw sheet)- 2 XXL adult wipes

Indications:Ready to use, all-in-one, for using:

- In establishments in the event of risk of infection

- In home healthcare: for short periods

- In emergency transport, health crises, etc.

LES

600 ml 20 oz

600 ml 20 oz

THE

ProductProtects the bedpan (all models) It avoids soiling and splashes, conceals odors and micro-organisms. Fitted with an absorbent pad, it eliminates waste and urine, hazardous or not and offers optimal conditions for hygiene and safety.

Indications Patients in isolation, intensive care, resuscitation, digestive surgery, recovery room, A&E, maternity, follow-on care and rehabilitation Also in emergency health transport, ambulances, etc

Use

1. Open the box and tear off the first liner of the roll.

2. Place the bag over the bedpan. The bag protects the entire bedpan, the pad stays on the bottom of the covered pan (ultra-quick absorption of 600ml / 20oz of stool and urine)

3. Position directly under the patient’s buttocks The hypoallergenic bag and pad are dermatologically tested, and are specially designed for prolonged contact with all skin types (including the most sensitive skin). The patient can stay safely seated on the bedpan liner, even in cases of frequent or prolonged use.

4. Following use, remove the full bag, pull the drawstrings closed and tie a knot. If necessary, tie a knot in the bag itself. Do not throw into the toilet. Dispose of in common waste or according to current protocol.

www.drhelewa.care14

www.drhelewa.care15

commode lIner 600

LES

600 ml 20 oz

600 ml 20 oz

THE

protège wc 600

LES

600 ml 20 oz

600 ml 20 oz

THE

Product Protects the commode chair pail (standard)It avoids soiling and splashes, conceals odors and micro-organisms. Fitted with an absorbent pad, it eliminates waste and urine, hazardous or not and offers optimal conditions for hygiene and safety.

Indications home medical care, nursing homes, functional rehabilitation centres, in hospital: LTC, oncology (haematology, etc.), dialysis, patient in isolation.

Use1. Open the box and tear off the first liner of the roll. 2. The bag protects the entire pail, the pad stays on the bottom of the bag (ultra-quick absorption of 600ml / 20oz of stool and urine) 3. Position the covered pail into the commode. The enclosed pad ensures that no microcellulose or powder is dispersed into the bag or on the skin. Hypoallergenic, the bag and the pad are dermatologically tested to protect the caregiver (or any compromising situations on behalf of the patient). They are specially designed for prolonged contact with all skin types (including the most sensitive skin), even in cases of frequent or prolonged use. 4. Following use, remove the full bag, pull the drawstrings closed and tie a knot. If necessary, tie a knot in the bag itself. Do not throw into the toilet. Dispose of in common waste or according to current protocol.

Product Protects the toilet (bowl - and seat depending on use)It avoids soiling and splashes, conceals odors and micro-organisms. Fitted with an absorbent pad, it eliminates waste and urine, hazardous or not and offers optimal conditions for hygiene and safety.

Indications In the context of isolation for infection, for functional investigations or treatments with biocides (markers, chemotherapy, etc.) when the regulations prohibit discharge into water systems. Always works for all types of large commode buckets or bedpans (large models for obese patients), pans, and WCs.

Use1. Open the box and tear the first liner off the roll. 2. The bag protects the entire toilet bowl or seat, the pad lays on the bottom of the bag (ultra-quick absorption of 600ml / 20oz of stool and urine). 3. Sit down and use the toilet without flushing. The hypoallergenic bag and pad are dermatologically tested, and are specially designed for contact with all skin types (including the most sensitive skin). The patient can stay safely seated on the toilet bowel liner as long as necessary, even in cases of frequent or prolonged extended use. 4. Following use, remove the full bag, pull the drawstrings closed and tie a knot. If necessary, tie a knot in the sac itself. Do not throw into the toilet. Dispose of in common waste or according to current protocol.

2

3 4

1

600 ml 20 oz

21

3 4

600 ml 20 ozULTRA-RAPID

ABSORPTION

ULTRA-RAPID ABSORPTION 600 ml

20 oz600 ml

20 oz

Ref: C60020 - Bag 52 x 40cm1 Box = 1 roll of 20 bags

Ref: W60020 - Bag 52 x 40cm1 Box = 1 roll of 20 bags

www.drhelewa.care16

www.drhelewa.care17

vomIt bag 600 male urInal 600

LES

600 ml 20 oz

600 ml 20 oz

THE

LES

600 ml 20 oz

600 ml 20 oz

THE

Ref: V60020 - Bag 25 x 25cm1 Box = 1 roll of 20 bags

Ref: U60020 - Bag 20 x 40cm1 Box = 1 roll of 20 bags

ULTRA-RAPID ABSORPTION

ULTRA-RAPID ABSORPTION

600 ml 20 oz

600 ml 20 oz

Once full, the V models are closed for total sealing, particularly in the event

of risk of infection1- Bag before closing

2 - Pull on the ties3 - Lengthen the ties

(PEMD is designed for this)4 - Knot the ties around the bag

Once full, the V models are closed for total sealing, particularly in the event

of risk of infection1- Bag before closing

2 - Pull on the ties3 - Lengthen the ties

(PEMD is designed for this)4 - Knot the ties around the bag

1 12 23 34 4

ProductThis vomit bag «100% Protected Hands» is recommended in the event of nausea or vomiting, especially in the case of emergency operations or risk of infection. It prevents splashing as well as any soiling of the user’s hands or surroundings; it contains odors and locks in micro-organisms. Fitted with an absorbent pad, it eliminates vomit, thereby offering optimal conditions for hygiene and safety.

Indications Emergency interventions and transport (firemen, SDIS - Departmental Fire and Emergency Service, SAMU - Emergency Medical Aid Service, ambulance, etc.), and during all medical transport. Recovery room, pre- and post-operatively, oncology, geriatrics, particularly in the event of epidemics (gastroenteritis, norovirus, etc.).

Use1. Open the box and tear off the first vomit bag off the roll. Hold it by the hygienic integrated holder (patent®). 2. The vomit bag is ready for use, the hands are fully protected, the pad lays at the bottom of the bag (ultra-quick absorption of 600ml / 20oz of vomit) 3. Vomit directly into the bag. The wrapper around the pad ensures that no micro-cellulose or powder is dispersed into the bag or on the skin. Hypoallergenic, the bag and the pad are dermatologically tested to protect the caregiver or the patient in their tasks, even in cases of frequent or prolonged use. 4. Following use, remove the full bag, pull the drawstrings closed and tie a knot. If necessary, tie a knot in the bag itself. Do not throw into the toilet. Dispose of in common waste or according to current protocol.

ProductThis absorbent urinal «100% Protected Hands» replaces plastic urinals (no more cleaning or spills) in cases of reduced mobility, emergency operations or risk of infection. It prevents splashing as well as any soiling of the user’s hands or surroundings; it contains odors and locks in micro-organisms. Fitted with an absorbent pad, it eliminates urine, thereby offering optimal conditions for hygiene and safety.

Indications isolation cases, A&E, urology, dialysis, long stay, oncology, intensive and palliative care (to limit the use of nappies), health and emergency transport: SAMU, firemen, ambulances, etc.

Use1. Open the box and tear off the first male urinal from the roll. Hold it by the hygienic integrated holder (patent®) 2. The urinal bag is ready for use, the hands are fully protected, the pad lays at the bottom of the bag ( (ultra-quick absorption of 600ml / 20oz of urine) 3. Urinate directly into the bag. The wrapper around the pad ensures that no micro- cellulose or powder is dispersed into the bag or on the skin. Hypoallergenic, the bag and the pad are dermatologically tested to protect the caregiver or the patient in their tasks, even in cases of frequent or prolonged use. 4. Following use, remove the full bag, pull the drawstrings closed and tie a knot. If necessary, tie a knot in the bag itself. Do not throw into the toilet. Dispose of in common waste or according to current protocol.

2

3 4

600 ml 20 oz

1

3 4

600 ml 20 oz

1 2

www.drhelewa.care18

www.drhelewa.care19

Bathing a patient in bed, a source of contaminationand risk factor for the more fragile patients

Several studies have shown: During a traditional bed bath, the basin and water can be major sources of of bacterial contamination1, a risk factor especially for fragile or immuno-depressed patients.

62% to 98% of bathing basins arecontaminated3: the patient risks being contaminated.4

The mechanical friction during a traditionalbath deposits cutaneous flora in the basin4. MRSA, Acinetobacter, Pseudomonas., E. Coli and many other pathogens have been detected in bathwater as well as in the environment (nurses’ gloved hands, objects handled, towels, etc).1

Tap water may also be a potential source ofwaterborne nosocomial infections.6

With age, the skin tends to wither and dry out, it is less supple and less firm (parchment effect).The traditional bath may then be too aggressive, particularly in certain areas of the body.

The friction of rubbing a patient during abed bath may present a number of risks forintegrity of the skin.6

The appearance of tears in the skin may bedue to a trigger factor such as a bed bath.7

Caregivers bathe the patient and change any soiled protection with protective gloves. Nevertheless, many studies attest to the risks of being exposed to excreta.A risk analysis shows that exposure may happenthrough contamination of the hands or the professional clothing.7

Urinary tract infections are the most common bacterial infections in hospitals (36% of all infections), 80% of these infections are associated with the use of a vesical catheter2 (the most common of all nosocomial infections, more than 1 million cases per year in the US, 200,000 in France).

Another study4 indicated that:The average cost of bed baths over 6 weeks, per resident, were estimated at €218 in the experimental group (single-use glove bathing without rinsing) and at €232 in the control group (traditional bed bath with basin and water, etc.).Results: 5% savings / costs

Single-use glove, bathing without rinsing: Recommended use

Lengthof bath time

Preparation

Bathing the patient

Post-bath cleaning

Total

Result

Single-use glove, bathing without rinsing

4 min.

21 min.

4 min.

29 min.

Traditional bed bath (basin + water, etc.)

5 min.

26 min.

5 min.

36 min.

Patient preferences for the bathing method

51 patients surveyed

Caregiver preferences for the bathing method

54 caregivers surveyed

Bathing without rinsing, single use

24 (47%)

47 (87%)

Traditional bed bath (Basin + water, etc.)

11 (22%)

6 (11%)

No preference

16 (31%)

1 (2%)

20% time saved

urInary InfectIons: proven decrease

cost control: proven savIngs3

patIents and caregIvers: proven preference3

Bathing without rinsing can therefore Be considered as the most efficient solution4

Sources (extracts and adaptations): Photos : Giving a Patient a Bed Bath, Hawknurse - https://www.youtube.com/watch?v=hYXYcOHT6aE - 1. Shannon RJ, et al., J Healthcare Safety, Compliance & Infection Control. Apr 1999;3(4):180-4. 2. Carr D, Adv in Skin andWound Care. Février 2009;22(2). 3. Lineweaver L, et al., Bugs Be Gone: Identify Potential Source of HAIs, the Basin. Poster presented at Institute for Healthcare Improvement (IHI), Orlando, FL, December 2007. 4. O’Flynn J, Kosair Children’s Hospital. Patient bath basins are a potential risk factor for HAIs in acute care. 5-Anaissie EJ, Penzak SR, DIgnani C, Arch Intern Med. 8 Jul 2002;162(13):1483-92. 6. Bryant RA, Rolstad BS, OstWound Mgmt. June 2001;47(6):18-27 7- Kimberly LeBlanc, Dawn Christensen, Heather L. Orsted, David H. Keast, Wound Care Canada, Volume 6, Number 1, 2008 & Sylvie Meaume, Lacérations cutanées de la peau chez la personne âgée, Soins N°697 juillet Août 2005 - 8- extrait de ACTUALISATION DES PRÉCAUTIONS STANDARD - HYGIÈNES - VOLUME XXV - N° HORS SÉRIE - JUIN 2017.

Sources (extracts and adaptations): 1. Stone S, et al., Removal of bath basins to reduce catheter-associated urinary tract infections. Poster presented at APIC 2010, New Orleans, LA, July 2010. - 2. Infections urinaires nosocomiales Martine BUTREAU-LEMAIRE, Henry BOTTO - Service d’Urologie, CMC Foch, Suresnes, France - Progrès en Urologie (1997) - 3 -Scand J Caring Sci; 2014 - Elderly patients’ and nurses’ assessment of traditional bedbath compared to prepacked single units, Lis Horstmann Nøddeskou, Lars E. Hemmingsen, Britta Hørdam - 4 International Journal of Nursing Studies, Volume 52, Issue 1, January 2015, Pages 112-120 , Cost-consequence analysis of “washing without water” for nursing home residents (Schoonhoven L, van Gaal BG, Teerenstra S, Adang E, van der Vleuten C, van Achterberg T).

Decline in number of Catheter-associated Urinary Tract Infections (CAUTI)

Rate of CAUTI/1000 survey days (from sept. 08 to apr. 10)

Pre-study period Study period

C A U T I

IMPLANTATI

ON

A poster1 presented at APIC* 2010 illustrated That by eliminating basins and replacing the traditional bed bath with a bath without rinsing, the rate of urinary tract infections associated with vesical catheters dropped by 78% in 6 months.*APIC: Association for Professionals in Infection Control and Epidemiology (USA)

www.drhelewa.care20

www.drhelewa.care21

Without any risk of contamination, suitable for the most fragile patients

The use of gloves when changing a patient’s soiled protection2

The use of gloves when bathing a patient2

* The entire series of tasks includes reinstalling the patient.

Scientific recommendations and product features

Moreover, a study conducted in 199 bathing sessions assessed “the use of single-use gloves for bathing bedridden patients4 and concluded that:

“The average bathing time takes 16.77 minutes. 43 patients felt a sensation of freshness, 31 patients a sensation of dampness, 11 patients a sticky sensation

and there were 4 cases of irritation. In addition to the primary goal of the method, which is to reduce the risk of spreading infection, there is thus a certain appeal to using single-use gloves. Optimizing the material in gloves and improving the cleanser on the

glove would lead to favorable opinions from caregivers and patients...”

The material of the glove should meet the most stringent demands(thick, non-woven and ultra soft, pleasant hypoallergenic lotion)

A plastic film inside the wash gloveprotects the caregiver’s glove and ensures safety during bathing,

shampooing and changing of soiled protections

Caregivers bathe the patient and change any soiled protections with protective gloves. Nevertheless, many studies attest to the risks of being exposed to excreta1, particularly when interrupted in their tasks2. “Because of consequences that are sometimes underestimated, excreta management requires that health professionals increase their vigilance. Risk analysis shows that exposure may happen through the contamination of hands or professional clothing. A study has shown that 23 to 65% of healthcare professionals have been exposed to accidental splashing.3”“Out of 230 baths and changing of soiled protections, 45 tasks were interrupted during bathing, 8 during changing. In 57.8% (26/45) of cases concerning bathing and 50% (4/8) during the changing of protections, tasks were interrupted without having the caregiver remove their gloves.”2

No gloves

16/120 (13.3%)

One single pair for the entire set

of tasks*

56/120 (46.7%)

One single pair for just changing the

protection

46/120 (38.3%)

Two pairs of gloves to carry out the entire

series of tasks*

2/120 (1.7%)

No gloves

12/120 (10%)

One single pairfor bathing

intimate areas

50/120 (41.7%)

One single pair for the entire bathing

session

54/120 (45%)

One pair for bathing intimate areas One pair for the rest

of the body

4/120 (3.3%)

bathIng wIthout rInsIng,wIth sIngle-use gloves

Sources (extracts and adaptations):1– Extrait de ACTUALISATION DES PRÉCAUTIONS STANDARD - HYGIÈNES - VOLUME XXV - N° HORS SÉRIE - JUIN 20174 - 2 – Synthèse de Évaluation des pratiques d’utilisation des gants de soins au cours d’actes de nursing - L. Thiriet, K. Jeunesse, A. Gizzi, B. Ibarissène Unité d’hygiène hospitalière – Centre hospitalier – Sedan - HYGIÈNES - 2011 - Volume XIX - n° 5 3– Davanzo E, Frasson C, Morandin M, Trevisan A. Occupational blood and body fluid exposure of university health care workers. Am J Infect Control 2008; 10: 753-756 4 - Extrait de Delpech, Laura ; Dubaele, JM ; Dupuis, C ; Guyot, F ; Evrard, MP ; Ducrocq, MA ; Dubois, C ; Belmekki, M Hygiènes. 2012/09; XX (4) : 237-240.

INTERIORLINING

ULTRA-SOFT

SHAMPOO

BATHING

Technical features

Non-woven glove: 90 g/m², with 3D waffling, 40% viscose, lined with a PE 25µ film, pre-moistened with a hypoallergenic lotion, dermatologically tested

Glove: Non-woven with a high percentage of viscose (40%), ultra-soft, thick 90 g/m2 and waffled for good, non-aggressive detersion of the skin, lined with a protective PE 25mic. film, impermeable to prevent any soiling of the caregiver’s hands.

Hypoallergenic, no-rinse cleansing lotion – pH neutral, with no soap, alcohol, triclosan or silicone, non-lathering, with no parabens - 3 dermatologically tests conducted and available upon request: HET CAM, hypoallergenicity test, patch test

Can be heated in a microwave for more comfortOpen the package slightly beforehand. Maxi. 40°C / 100°F

MOISTURIZING, PROTECTIVENO-RINSE BATHING

OR SHAMPOO LOTION

www.drhelewa.care22

www.drhelewa.care23

New no-rinse bath and shampoo glovesPre-moistened bath and shampoo “infection control” glove

Caregivers’ hands “100% protected”: internal plastic film barrier for “infection control” bathing.

Ideal for bedridden, incontinent or dependent patients and for infection control

THE

DescriptionMoistened gloves for daily, no-rinse “hands 100% protected” bathing.Materials: Non-woven, waffled, ultra-soft with a high percentage of viscose with impermeable lining. Cleansing lotion, no-rinse, hypoallergenic and enrichedwith Vitamin E, Provitamin B5, Aloe Vera, chamomille and glycerin for moisturizing, hydrating and protecting the skin.

IndicationsSuitable for all skin and body types, especially for the buttocks and perineal areas.Ideal for bedridden, incontinent or dependent patients and for controlling risks of infection.Other indications: No time to give a traditional bath, no running water, during health transport and emergency situations.

UseInstructions: Slip on the hand (preferably protected by an examination glove), the caregiver’s hand is 100% protected - Bathe the skin according to the existing protocol, no need to rinse - The hydrating lotion forms a protective layer over the skin. No need to dry.

ReferenceRef: ICBATH12: 1 pack of 12 gloves

1

2 3

4

7

8

BATHING PROTOCOL:8 areas to wash with 2, 3, 4, 6 or 8 gloves

(depending on patient condition and current protocol)

DescriptionMoistened gloves for daily, no-rinse “hands 100% protected” shampoo.Materials: Non-woven, waffled, ultra-soft with a high percentage of viscose with impermeable lining. Cleansing lotion, no-rinse, hypoallergenic and enriched with Vitamin E, Provitamin B5, Aloe Vera, chamomille and allantoin for moisturizing, hydrating and protecting the hair and the scalp.

IndicationsSuitable for all scalp and hair types.Ideal for bedridden, incontinent or dependent patients and for controlling risks of infection.Other indications: No time to give a traditional shampoo, no running water, during health transport and emergency situations

UseInstructions: Take a shampoo glove (two in the case of long hair) and slip it on the hand (preferably protected by a Vynil-type examination glove), close the pack - Wash the hair (massaging the scalp); the product does not need to be rinsed out - Gently towel dry the hair and then comb or brush as usual.

ReferenceRef: ICSHAMP12: 1 pack of 12 gloves

SHAMPOOING PROTOCOL:2 areas to wash with 1, 2, 3 or 4 gloves(depending on patient condition, hair length

and current protocol)

11

2

NEW SUPER-ABSORBENT HYGIENIC BAGSBedpan liner - Commode liner - Toilet bowl liner - Male urinal - Vomit bag

New! 2 international patents…THE

Patented integrated holder: caregiver’s hands 100% protected

600 ml 20 oz

NEW NO-RINSE BATHING & SHAMPOO WET WASHGLOVES

After creating the absorbent hygienic bags in 2001, Dr Helewa continues to innovate in the interest of the hygiene of dependent patients and emergency operations.HOSPITAL - HOME HEALTHCARE - EMERGENCY

Patented « Alveol Technology » super-absorbent pad: does NOT release powder, absorbs more and faster

The only hypoallergenic & dermatologically tested absorbent hygienic bags of the market

Infection control bathing and shampoo wet washgloves

THE

Caregiver’s hands are 100% protected : Internal plastic barrier film for an “infection control” hygiene. Ideal for bedridden, incontinent, dependent people ; and for infection control.

… and many more innovative hygiene, care & infection control products,

at guaranteed best price!

Products Dr Helewa sas, 75006 Paris – France : www.drhelewa.care @ : [email protected]

Medistock sas, 69960 CORBAS – France : www.medistock.fr - @ : [email protected] - Certifié EN / ISO 13485 : 2012are manufactured by